{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:57:53Z","timestamp":1788965873681,"version":"build-2803163510"},"reference-count":45,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2026.2112","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:28:59Z","timestamp":1769174939000},"page":"1-10","source":"Crossref","is-referenced-by-count":1,"title":["Exploratory transcriptomics and\n                    <i>in vivo<\/i>\n                    analyses of suramin in tongue squamous cell carcinoma"],"prefix":"10.3892","volume":"24","author":[{"given":"Wataru","family":"Kakuguchi","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Division of Oral Pathobiological Science, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of Head and Neck, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Division of Oral Pathobiological Science, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nako","family":"Maishi","sequence":"additional","affiliation":[{"name":"Department of Vascular Biology and Molecular Pathology, Division of Oral Pathobiological Science, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Vascular Biology and Molecular Pathology, Division of Oral Pathobiological Science, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Nomura","sequence":"additional","affiliation":[{"name":"Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060\u20110812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Otsuguro","sequence":"additional","affiliation":[{"name":"Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060\u20110812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Maenaka","sequence":"additional","affiliation":[{"name":"Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060\u20110812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ohiro","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Division of Oral Pathobiological Science, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"key20260210090335_b1-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00015458.2023.2291295","article-title":"Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): A critical update and consensus statement","volume":"124","author":"Coropciuc","year":"2024","journal-title":"Acta Chir Belg"},{"key":"key20260210090335_b2-BR-24-3-02112"},{"issue":"11","key":"key20260210090335_b3-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-023-08027-7","article-title":"100 years since the publication of the suramin formula","volume":"123","author":"Steverding","year":"2023","journal-title":"Parasitol Res"},{"key":"key20260210090335_b4-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"e01168","DOI":"10.1128\/AAC.01168-19","article-title":"100 years of suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"115814","key":"key20260210090335_b5-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115814","article-title":"Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin","volume":"168","author":"Zaragoza-Huesca","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"key20260210090335_b6-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: A small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"key20260210090335_b7-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1002\/cam4.1877","article-title":"Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells","volume":"7","author":"Kakuguchi","year":"2018","journal-title":"Cancer Med"},{"key":"key20260210090335_b8-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1200\/JCO.2000.18.7.1440","article-title":"Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone","volume":"18","author":"Small","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20260210090335_b9-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.actbio.2018.12.010","article-title":"Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles","volume":"84","author":"Cheng","year":"2019","journal-title":"Acta Biomater"},{"key":"key20260210090335_b10-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/bioinformatics\/btp612","article-title":"DEGseq: An R package for identifying differentially expressed genes from RNA-seq data","volume":"26","author":"Wang","year":"2010","journal-title":"Bioinformatics"},{"issue":"6077","key":"key20260210090335_b11-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41749-x","article-title":"Thalamocortical control of cell-type specificity drives circuits for processing whisker-related information in mouse barrel cortex","volume":"14","author":"Young","year":"2023","journal-title":"Nat Commun"},{"key":"key20260210090335_b12-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/bjc.1993.45","article-title":"Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro","volume":"67","author":"Foekens","year":"1993","journal-title":"Br J Cancer"},{"key":"key20260210090335_b13-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.18632\/oncotarget.23411","article-title":"The DNA methyl-transferase protein DNMT1 enhances tumor-promoting properties of breast stromal fibroblasts","volume":"9","author":"Al-Kharashi","year":"2017","journal-title":"Oncotarget"},{"key":"key20260210090335_b14-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1016\/j.apsb.2024.07.022","article-title":"Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells carcinoma cells via HuR-mediated mRNA stabilization","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"key20260210090335_b15-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3892\/mmr.2017.8010","article-title":"HuR induces inflammatory responses in HUVECs and murine sepsis via binding to HMGB1","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"key20260210090335_b16-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10555-007-9105-8","article-title":"The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2","volume":"27","author":"Stetler-Stevenson","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"key20260210090335_b17-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"9739","key":"key20260210090335_b18-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"796588","key":"key20260210090335_b19-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.796588","article-title":"Expression of TIMPs and MMPs in ovarian tumors, ascites, ascites-derived cells, and cancer cell lines: Characteristic modulatory response before and after chemotherapy treatment","volume":"11","author":"Escalona","year":"2022","journal-title":"Front Oncol"},{"issue":"e000604","key":"key20260210090335_b20-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000604","article-title":"Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo","volume":"3","author":"Guns","year":"2017","journal-title":"RMD Open"},{"key":"key20260210090335_b21-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/mol.117.109397","article-title":"Suramin inhibits osteoarthritic cartilage degradation by increasing extracellular levels of chondroprotective tissue inhibitor of metalloproteinases 3","volume":"92","author":"Chanalaris","year":"2017","journal-title":"Mol Pharmacol"},{"key":"key20260210090335_b22-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/s41416-023-02442-4","article-title":"The role of TXNIP in cancer: A fine balance between redox, metabolic, and immunological tumor control","volume":"129","author":"Deng","year":"2023","journal-title":"Br J Cancer"},{"issue":"1483","key":"key20260210090335_b23-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091483","article-title":"Mammalian metallothionein-2a and oxidative stress","volume":"17","author":"Ling","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"107","key":"key20260210090335_b24-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"153213","key":"key20260210090335_b25-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153213","article-title":"Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"151415","key":"key20260210090335_b26-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151415","article-title":"Exploring the dynamic role of circulating soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a diagnostic and prognostic marker; a review","volume":"751","author":"Niroshika","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260210090335_b27-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3892\/ol.2016.5537","article-title":"Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis","volume":"13","author":"Deng","year":"2017","journal-title":"Oncol Lett"},{"key":"key20260210090335_b28-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-08-0025","article-title":"PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma","volume":"68","author":"He","year":"2008","journal-title":"Cancer Res"},{"key":"key20260210090335_b29-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1084\/jem.20172018","article-title":"PIK3IP1\/TrIP restricts activation of T cells through inhibition of PI3K\/Akt","volume":"215","author":"Uche","year":"2018","journal-title":"J Exp Med"},{"key":"key20260210090335_b30-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1126\/science.1063486","article-title":"Coupling of the TCR to integrin activation by Slap-130\/Fyb","volume":"293","author":"Peterson","year":"2001","journal-title":"Science"},{"issue":"140","key":"key20260210090335_b31-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1038\/msb4100180","article-title":"Network-based classification of breast cancer metastasis","volume":"3","author":"Chuang","year":"2007","journal-title":"Mol Syst Biol"},{"key":"key20260210090335_b32-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrc3556","article-title":"The DREAM complex: Master coordinator of cell cycle-dependent gene expression","volume":"13","author":"Sadasivam","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20260210090335_b33-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"E600","DOI":"10.1152\/ajpendo.00147.2013","article-title":"Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 \u03b2-cell line","volume":"305","author":"Krautkramer","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"101978","key":"key20260210090335_b34-BR-24-3-02112","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101978","article-title":"TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf\/MEK\/ERK signaling pathway","volume":"45","author":"Tian","year":"2024","journal-title":"Transl Oncol"},{"key":"key20260210090335_b35-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20260210090335_b36-BR-24-3-02112","first-page":"3585","article-title":"Suramin inhibits growth of human osteosarcoma xenografts in nude mice","volume":"51","author":"Walz","year":"1991","journal-title":"Cancer Res"},{"key":"key20260210090335_b37-BR-24-3-02112","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-3565(24)29247-8","article-title":"Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors","volume":"299","author":"Zhang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key20260210090335_b38-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/gyno.1995.1176","article-title":"Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II)","volume":"58","author":"Kikuchi","year":"1995","journal-title":"Gynecol Oncol"},{"key":"key20260210090335_b39-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s002800050884","article-title":"Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice","volume":"43","author":"Church","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20260210090335_b40-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"key20260210090335_b41-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2203\/dose-response.09-049.Reynolds","article-title":"Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer","volume":"8","author":"Reynolds","year":"2010","journal-title":"Dose Response"},{"key":"key20260210090335_b42-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s11095-006-0165-1","article-title":"Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development","volume":"23","author":"Chen","year":"2006","journal-title":"Pharm Res"},{"key":"key20260210090335_b43-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/brain\/119.6.2039","article-title":"A prospective study of suramin-induced peripheral neuropathy","volume":"119 (Pt 6)","author":"Chaudhry","year":"1996","journal-title":"Brain"},{"key":"key20260210090335_b44-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/DDDT.S416325","article-title":"Phase I, single-dose study to assess the pharmacokinetics and safety of suramin in healthy Chinese volunteers","volume":"17","author":"Wu","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"key20260210090335_b45-BR-24-3-02112","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/1871528114666150529100957","article-title":"Suramin attenuated inflammation and reversed skin tissue damage in experimentally induced atopic dermatitis in mice","volume":"13","author":"Alyoussef","year":"2015","journal-title":"Inflamm Allergy Drug Targets"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:03:42Z","timestamp":1770707022000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2026.2112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1,23]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2026.2112","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}